Sign Up Today and Learn More About Bluejay Therapeutics Stock
Invest in or calculate the value of your shares in Bluejay Therapeutics or other pre-IPO companies through EquityZen's platform.
Bluejay Therapeutics Stock
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
About Bluejay Therapeutics Stock
Founded
2019
Headquarters
San Francisco, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Bluejay Therapeutics Press Mentions
Stay in the know about the latest news on Bluejay Therapeutics
Bluejay hatches $182m funding egg for hepatitis drugs
pharmaphorum • Aug 04, 2024
Bluejay Therapeutics Presents Positive Preliminary BJT-778 Data from Phase 2 Clinical Trial in Chronic Hepatitis D at ...
globenewswire • Jul 05, 2024
Bluejay Therapeutics Receives Positive Opinion on Orphan Designation from the European Medicines Agency for BJT ...
globenewswire • Jul 05, 2024
Flying high with $182M, Bluejay Therapeutics advances BJT-778
bioworld • Jun 04, 2024
Bluejay Therapeutics Raises $182M in Series C Financing
finsmes • Jun 04, 2024
Bluejay Therapeutics Management
Leadership team at Bluejay Therapeutics
Chief Scientific Officer
Hassan Javanbakht
Board Member
William Rutter
Join now and verify your accreditation status to gain access to:
- Bluejay Therapeutics current valuation
- Bluejay Therapeutics stock price
- Available deals in Bluejay Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Bluejay Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Bluejay Therapeutics through EquityZen funds. These investments are made available by existing Bluejay Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Bluejay Therapeutics stock?
Shareholders can sell their Bluejay Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
